Skip to main content
Signal8
Kurzius Lawrence Erik profile photo

Lawrence Erik Kurzius

CIK: 0001352090

Transaction Breakdown

Open Market Buys (P)8 (15.1%)

High conviction signal

Open Market Sales (S)11 (20.8%)

Position reduction

Option Exercises (M)9 (17.0%)

Derivative conversions

Awards (A)14 (26.4%)

Compensation grants

Other (G, F, J, C, D, …)11 (20.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (4)

Lamb Weston Holdings, Inc. logo
LW

Lamb Weston Holdings, Inc.

Director
COOPER COMPANIES, INC. logo
COO

COOPER COMPANIES, INC.

Director
Elanco Animal Health Inc logo
ELAN

Elanco Animal Health Inc

Director
MCCORMICK & CO INC logo
MKC

MCCORMICK & CO INC

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (53 total)

  • Lamb Weston Holdings, Inc. logo
    LW

    Lamb Weston Holdings, Inc.

    Oct 8, 2026
    Award(A)
    Direct
    5.5K shares-
  • COOPER COMPANIES, INC. logo
    COO

    COOPER COMPANIES, INC.

    Sep 16, 2026
    Purchase(P)
    Direct
    10K shares at avg. $54.93$549K
  • COOPER COMPANIES, INC. logo
    COO

    COOPER COMPANIES, INC.

    Sep 14, 2026
    Purchase(P)
    Direct
    10K shares at avg. $53.91$539K
  • Elanco Animal Health Inc logo
    ELAN

    Elanco Animal Health Inc

    Aug 20, 2026
    Purchase(P)
    Direct
    40K shares at avg. $23.40$936K
  • MCCORMICK & CO INC logo
    MKC

    MCCORMICK & CO INC

    Aug 10, 2026
    Exercise(M)
    Direct
    205.5K shares at avg. $49.02$10.1M
  • MCCORMICK & CO INC logo
    MKC

    MCCORMICK & CO INC

    Aug 10, 2026
    Sale(S)
    Direct
    205.5K shares at avg. $52.69$10.8M
  • Elanco Animal Health Inc logo
    ELAN

    Elanco Animal Health Inc

    May 21, 2026
    Award(A)
    Direct
    12.2K shares-
  • Elanco Animal Health Inc logo
    ELAN

    Elanco Animal Health Inc

    May 21, 2026
    Award(A)
    Direct
    4.7K shares-
  • COOPER COMPANIES, INC. logo
    COO

    COOPER COMPANIES, INC.

    Apr 1, 2026
    Award(A)

    Restricted Stock Units

    Direct
    3.8K shares-
  • COOPER COMPANIES, INC. logo
    COO

    COOPER COMPANIES, INC.

    Apr 1, 2026
    Exercise(M)
    Direct
    3.3K shares-
  • MCCORMICK & CO INC logo
    MKC

    MCCORMICK & CO INC

    Feb 12, 2026
    Exercise(M)
    Direct
    50K shares at avg. $49.02$2.5M
  • MCCORMICK & CO INC logo
    MKC

    MCCORMICK & CO INC

    Feb 12, 2026
    Sale(S)
    Direct
    50K shares at avg. $71.63$3.6M
  • MCCORMICK & CO INC logo
    MKC

    MCCORMICK & CO INC

    Jan 19, 2026
    Award(A)
    Direct
    50.2K shares-
  • MCCORMICK & CO INC logo
    MKC

    MCCORMICK & CO INC

    Jan 13, 2026
    Sale(S)
    Direct
    50K shares at avg. $67.43$3.4M
  • MCCORMICK & CO INC logo
    MKC

    MCCORMICK & CO INC

    Jan 13, 2026
    Exercise(M)
    Direct
    50K shares at avg. $49.96$2.5M
  • COOPER COMPANIES, INC. logo
    COO

    COOPER COMPANIES, INC.

    Dec 17, 2025
    Purchase(P)
    Direct
    2K shares at avg. $82.50$165K
  • Elanco Animal Health Inc logo
    ELAN

    Elanco Animal Health Inc

    Dec 12, 2025
    Purchase(P)
    Direct
    10K shares at avg. $21.30$213K
  • Elanco Animal Health Inc logo
    ELAN

    Elanco Animal Health Inc

    Nov 28, 2025
    Award(A)
    Direct
    10.3K shares-
  • MCCORMICK & CO INC logo
    MKC

    MCCORMICK & CO INC

    Nov 11, 2025
    Sale(S)
    Indirect
    5.9K shares at avg. $64.54$381K
  • MCCORMICK & CO INC logo
    MKC

    MCCORMICK & CO INC

    Nov 11, 2025
    Sale(S)
    Indirect
    6.6K shares at avg. $64.54$424K
  • MCCORMICK & CO INC logo
    MKC

    MCCORMICK & CO INC

    Nov 11, 2025
    Sale(S)
    Indirect
    6.6K shares at avg. $64.54$424K
  • MCCORMICK & CO INC logo
    MKC

    MCCORMICK & CO INC

    Nov 11, 2025
    Sale(S)
    Indirect
    14.1K shares at avg. $64.54$907K
  • MCCORMICK & CO INC logo
    MKC

    MCCORMICK & CO INC

    Nov 11, 2025
    Sale(S)
    Indirect
    5.9K shares at avg. $64.54$381K
  • MCCORMICK & CO INC logo
    MKC

    MCCORMICK & CO INC

    Oct 8, 2025
    Sale(S)
    Direct
    50K shares at avg. $65.86$3.3M
  • MCCORMICK & CO INC logo
    MKC

    MCCORMICK & CO INC

    Oct 8, 2025
    Exercise(M)
    Direct
    50K shares at avg. $49.96$2.5M

1-25 of 53

About Kurzius Lawrence Erik

Kurzius Lawrence Erik (SEC CIK 0001352090) files insider reports with the SEC as Director of Lamb Weston Holdings, Inc. (LW), Director of COOPER COMPANIES, INC. (COO) and Director of Elanco Animal Health Inc (ELAN). Signal8 also holds filings tied to 1 other company.

Signal8 holds 34 ownership filings by Kurzius Lawrence Erik (1 Form 3, 33 Form 4), filed between Sep 11, 2024 and Oct 9, 2026. Those filings report 53 transactions, from Jul 22, 2024 to Oct 8, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kurzius Lawrence Erik's filings is in EAGLE, ID.

Recent filings by Kurzius Lawrence Erik

  • Oct 8, 2026: Grant or award of LW shares (Form 4, code A).
  • Sep 16, 2026: Open-market purchase of COO shares (Form 4, code P).
  • Sep 14, 2026: Open-market purchase of COO shares (Form 4, code P).
  • Aug 20, 2026: Open-market purchase of ELAN shares (Form 4, code P).
  • Aug 10, 2026: Option exercise of MKC shares (Form 4, code M).

Other insiders filing for Lamb Weston Holdings, Inc. (LW)

How to read Form 4 transaction codes